Search

Search Results
Results 1071 - 1080 of 1163 for Diabetes Type II
  • Understanding Exercise Intolerance And Low Fitness Levels
    Health - 4 May 2026
    Exercise tolerance reflects the ability to sustain physical activity and is influenced by cardiovascular, pulmonary, and metabolic function.
  • Iscover
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Iscover intended for persons living in Australia.
  • Clopidogrel Winthrop
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop intended for persons living in Australia.
  • Plavix
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Plavix intended for persons living in Australia.
  • Olsetan
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Olsetan intended for persons living in Australia.
  • Karvezide
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Avapro HCT
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.
  • Rethinking early-phase MASLD trials
    White Paper - 17 Apr 2026
    Explore new approaches to early-phase MASLD trials, addressing metabolic complexity and improving clinical relevance in study design.
  • Velsipity
    Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Nextstellis
    Drug - 5 Mar 2026
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback